Transfection Reagent and Equipment Market Estimated to Witness Exponential CAGR Growth of 9.6% by 2030, Size, Share, Trends, Rising Demand, Dynamics and Opportunity Analysis

Rhea-AI Summary

Data Bridge Market Research's latest report highlights the global transfection reagent and equipment market, projected to reach USD 2,284,494.00 thousand by 2030, growing at a CAGR of 9.6% from 2023 to 2030. Key factors driving this growth include the rising prevalence of chronic diseases and the demand for gene therapy. The report outlines various applications of transfection methods, such as in immunotherapy and agriculture. However, challenges such as high instrument costs and selective reagent effectiveness may restrain market expansion. Notable developments include Mirus Bio's GMP platform expansion and BOC Sciences' RNA transfection kits.

Positive

• Projected growth of the transfection reagent and equipment market to USD 2,284,494.00 thousand by 2030.
• CAGR of 9.6% driven by increased demand for gene therapy and chronic disease treatment.
• Emerging markets provide growth opportunities for market players.

Negative

• High cost of instruments may hinder market accessibility.
• Selective effectiveness of transfection reagents could limit market adoption.
• Potential cell damage from transfection methods could restrain growth.

CHICAGO, March 15, 2023 /PRNewswire/ -- Data Bridge Market Research has recently published a Report, titled, "Transfection Reagent and Equipment Market" The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. Market insights underlined in Transfection Reagent and Equipment report will help foster a future shaped by growth in the face of unprecedented health and economic challenges. Market data and information covered here bridges the strategic gap with revenue impacting solutions. It also aids outwit the challenges including the economic challenges created by covid-19. Market research report services have modernized strategy making with actionable insights and with the largest industry and technology coverage that is never seen before in the industry. While delivering Transfection Reagent and Equipment report to the client, the timeline is religiously followed. 

With unparalleled level of resilience and integrated approaches, DBMR team works hard to provide the finest Transfection Reagent and Equipment market report. This report helps unearth the best market opportunities and foster efficient information for the business to thrive in the market. The market document provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process. We believe in delivering the best before the clock ticks deadline. Moreover, after delivering Transfection Reagent and Equipment report to the client, an extremely particular post-sales support is provided to the clients about addressing all the queries and requests generated by them with phenomenal performance.

Data Bridge Market Research analyzes that the global transfection Reagent and equipment market is expected to reach the value of USD 2,284,494.00 thousand by 2030, at a CAGR of 9.6% during the forecast period.

Download Sample Copy of Transfection Reagent and Equipment Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-transfection-reagents-and-equipment-market

The transfection method is used to introduce RNA, DNA or protein products in cells to alter the phenotype and genotype of the organism. The transfection method involves the new gene transfer or transferring a gene construct such as Clustered regularly interspaced short palindromic repeats (CRISPR) for genome editing purposes. Transfection has wide applications in the field of immunotherapy, gene therapy, and cell therapy, among others. Transfection involves both non-viral and viral-mediated transfection

The transfection method is used for several applications involving agriculture for crop protection and enhancing yield, for the production of synthetic biology products to enhance flavors and fragrances, and for enhancing single-cell protein, among others. The demand for transfection has increased in both developed and developing countries, and the reason behind this is the increasing occurrence of chronic diseases. The transfection market is growing due to the growing demand for chimeric genes and the utilization of biopharmaceuticals in the production of proteins. The market will grow in the forecast period due to the exploration of emerging markets, strategic initiatives by market players, and increasing government support.

The high cost of instruments, selective effectiveness of transfection reagent and cell damage induced by the transfection methods are expected to restrain the global transfection reagent and equipment market growth.

The market is growing due to several strategic initiatives adopted by market players involving acquisition, collaboration, and partnership.

Recent Developments

• In August 2021, Mirus Bio expanded the TransIT VirusGen platform for Good Manufacturing Practice (GMP) viral vector production to support cell and gene therapy development, process operations, and commercial production. The extension, referred to as TransIT VirusGen GMP Transfection Reagent, is designed to improve the packaging and delivery of vector DNA to suspension and adherent HEK 293 cell types to improve the production of recombinant adeno-associated viruses and lentiviral vectors.
• In April 2021, BOC Sciences announced the launch of two in vivo RNA transfection kits, namely siRNA in vivo transfection kits and mRNA in vivo transfection kits, suitable for in vivo transfection of siRNA and mRNA, respectively.

Some of the major players operating in the Transfection Reagent and Equipment market are:

• Mirus Bio LLC.
• Promega Corporation
• Polyplus Transfection
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• Lonza
• MaxCyte, Inc.
• Altogen Biosystems
• SBS Genetech
• FUJIFILM Irvine Scientific (A Subsidiary of FUJIFILM Holdings Corporation)
• Avanti Polar Lipids (A Subsidiary of Croda International Plc)
• PerkinElmer chemagen Technologie GmbH (A Subsidiary of PerkinElmer Inc.)
• Cytiva
• Geno Technology Inc., USA
• R&D Systems, Inc.
• Takara Bio Inc.
• Thermofisher Scientific Inc.
• Roche Molecular Systems, Inc. (A Subsidiary of F. Hoffmann-La Roche Ltd)
• QIAGEN
• OriGene Technologies, Inc.
• Applied Biological Materials Inc. (abm)
• Beckman Coulter, Inc. (A Subsidiary of Danaher)
• Amyris
• Codexis
• Autolus
• SignaGen Laboratories
• Impossible Foods Inc.
• Genlantis Inc.
• Ginkgo Bioworks
• Verve Therapeutics, Inc.
• Conagen, Inc.
• Poseida Therapeutics, Inc.
• Twist BioscienceTop of Form

Get Full PDF Research Report to Understand More @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-transfection-reagents-and-equipment-market

Opportunities:

EXPLORATION OF EMERGING MARKET

The transfection products have been shown as promising tools for the genetic engineering and proteomic industry. The top market for transfection products is in Europe and North America. By looking at the positive outcomes of these products, many market players are penetrating their roots in growing economies involving China and India, among others. The emerging market allows these market players to combat the loss that arises from the well-established market.

As emerging markets allow the market players to overcome the economic downturn specified to particular established markets, investment and exploration of emerging markets allow the market players to engage in the development and manufacturing of transfection products to attain lucrative growth. Thus, this signifies that exploring emerging markets is an opportunity to grow the global transfection Reagent and equipment market.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Transfection Reagent and Equipment market

Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market

Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Transfection Reagent and Equipment Market

Market Dynamics: Transfection Reagent and Equipment Market

• RISE IN THE PREVALENCE OF CHRONIC DISEASES

The prevalence of chronic diseases is increasing worldwide, leading to the demand for effective and accurate treatment. Transfection is used to deliver targeted modified genes to treat several genetic diseases. The transfection method is also used for the delivery of the CRISPR gene, which can enhance adaptive immunity and prevent an individual from different diseases.

The increasing cases of chronic diseases such as COVID-19 and other infectious diseases have led to the discovery of effective gene therapy products which can replace the defective gene with the correct gene. The transfection method is widely used for gene therapy, among others. As the demand for effective and accurate treatment is increasing worldwide, the demand for gene therapy and transfection method is also increasing. Moreover, several undergoing researches proving gene therapy to have the potential for chronic disease treatment are also increasing its demand among physicians and patients. This thus signifies that the rise in chronic disease prevalence is acting as a driver for the global transfection Reagent and equipment market growth.

• DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS

Synthetic biology is a new era of biology that incorporates the engineering principle into biology. Synthetic biology involves the chemical synthesis of DNA by combining the knowledge of genomics to reassemble the DNA genomes. The synthetic biology that sequences into the new genes involves genetic engineering, which incorporates the transfection method, among others. As the demand for synthetic biology products is increasing worldwide, the use of transfection products is also increasing.

The demand for synthetic biology products is increasing due to the increasing demand for effective and innovative products. The manufacturing of synthetic products enhances the demand for transfection products, as gene transfer can be accompanied by the transfection method, among others. Thus, this signifies that synthetic product development drives the global transfection Reagent and equipment market growth.

A comprehensive analysis will be provided covering the following points in the report:

• Executive Market Summary
• Scope of the Transfection Reagent and Equipment Report
• Key Finding and Recommendations
• Growth and Investment Opportunities
• Transfection Reagent and Equipment Market Value Chain/Supply Chain Analysis
• Transfection Reagent and Equipment Market Attractive Investment Proposition
• Competitive landscape and SWOT Analysis
• Transfection Reagent and Equipment Market Segmentation Outlook
• Regional Outlook
• Company Profiles of Key Players

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global Transfection Reagent and Equipment market over the period. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

To Gain More Insights about this Research, Visit @ https://www.databridgemarketresearch.com/reports/global-transfection-reagents-and-equipment-market

Key Industry Segmentation: Transfection Reagent and Equipment Market

Products

• Instruments
• Reagent & Kits

Stage

• Research
• Preclinical
• Clinical Phases
• Commercial

Type

• Transient Transfection Reagent And Equipment
• Stable Transfection Reagent And Equipment

Methods

• Non-Viral Methods
• Viral Methods

Types Of Molecule

• Plasmid Dna
• Dna Oligonucleotides
• Small Interfering Rna (Sirna)
• Proteins
• Ribonucleoprotein Complexes (Rnps)
• Others

Organism

• Bacteria
• Mammalian Cells
• Fungi
• Plants
• Virus

Application

• By Type
• In Vitro Application
• In Vivo Application
• Bioproduction
• Others
• By Industry
• Agriculture
• Synthetic Biology
• Others

End User

• Biopharma
• Cros
• Cmos/Cdmos
• Academia
• Hospitals
• Clinical Labs
• Others

Distribution Channel

• Direct Tender
• Retail Sales

Regional Analysis/Insights: Transfection Reagent and Equipment Market

The countries covered in this Transfection Reagent and Equipment market report are U.S., Canada, Mexico, Germany, France, Italy, U.K., Spain, Switzerland, Russia, Netherlands, Belgium, Turkey, and Rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Philippines, Indonesia, and Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Israel, Egypt, and Rest of the Middle East and Africa

In 2023, the North America region is dominating due to the presence of key market players in the largest consumer market with high GDP. U.S is expected to grow due to rise in the prevalence of chronic and rare diseases leading to increase in the use of transfection reagent and equipment.

North America is dominating the market due to the increasing investment in healthcare is expected to boost the market growth. The U.S. dominates North America region due to strong presence of key players. Germany dominates Europe region due to the increasing demand from emerging markets and expansion. China dominates Asia-Pacific region due to due to increasing customer inclinations towards advanced technological processes.

Table of Contents:

1.  Introduction

2.  Market Segmentation

3.  Executive Summary

4.  Premium Insights

5.  Global Transfection Reagent and Equipment Market: Regulations

6.  Market Overview

7.  Global Transfection Reagent And Equipment Market, By Products

8.  Global Transfection Reagent And Equipment Market, By Stage

9.  Global Transfection Reagent And Equipment Market, By Type

10.  Global Transfection Reagent And Equipment Market, By Methods

11.  Global Transfection Reagent And Equipment Market, By Types Of Molecule

12.  Global Transfection Reagent And Equipment Market, By Organism

13.  Global Transfection Reagent And Equipment Market, By Application

14.  Global Transfection Reagent And Equipment Market, By End User

15.  Global Transfection Reagent And Equipment Market, By Distribution Channel

16.  Global Transfection Reagent and Equipment Market, By Region

17.  Global Transfection Reagent and Equipment Market: Company Landscape

18.  SWOT Analyses

19.  Company Profile

20.  Questionnaires

21.  Related Reports

To Check the Complete Table of contents, click here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-transfection-reagents-and-equipment-market

Explore More Reports:

North America Transfection Reagent and Equipment Market, By Products (Reagent & Kits and Instruments), Stage (Research, Preclinical, Clinical Phases, and Commercial), Type (Transient Transfection Reagent and Equipment, Stable Transfection Reagent, and Equipment), Methods (Non-viral Methods and Viral Methods), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), and Others), Organism (Mammalian Cells, Plants, Fungi, Virus, and Bacteria), Application (In Vitro Application, In Vivo Application, Bioproduction and Others), End User (Biopharma, CROs, (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) https://www.databridgemarketresearch.com/reports/north-america-transfection-reagents-and-equipment-market

Europe Transfection Reagent and Equipment Market, By Products (Reagent & Kits and Instruments), Stage (Research, Preclinical, Clinical Phases, and Commercial), Type (Transient Transfection Reagent and Equipment, Stable Transfection Reagent, and Equipment), Methods (Non-viral Methods and Viral Methods), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), and Others), Organism (Mammalian Cells, Plants, Fungi, Virus, and Bacteria), Application (In Vitro Application, In Vivo Application, Bioproduction and Others), End User (Biopharma, CROs, (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) https://www.databridgemarketresearch.com/reports/europe-transfection-reagents-and-equipment-market

Asia-Pacific Transfection Reagent and Equipment Market, By Products (Reagent & Kits and Instruments), Stage (Research, Preclinical, Clinical Phases, and Commercial), Type (Transient Transfection Reagent and Equipment, Stable Transfection Reagent, and Equipment), Methods (Non-viral Methods and Viral Methods), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), and Others), Organism (Mammalian Cells, Plants, Fungi, Virus, and Bacteria), Application (In Vitro Application, In Vivo Application, Bioproduction and Others), End User (Biopharma, CROs, (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) https://www.databridgemarketresearch.com/reports/asia-pacific-transfection-reagents-and-equipment-market

Middle East and Africa Transfection Reagent and Equipment Market, By Products (Reagent & Kits and Instruments), Stage (Research, Preclinical, Clinical Phases, and Commercial), Type (Transient Transfection Reagent and Equipment, Stable Transfection Reagent, and Equipment), Methods (Non-viral Methods and Viral Methods), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), and Others), Organism (Mammalian Cells, Plants, Fungi, Virus, and Bacteria), Application (In Vitro Application, In Vivo Application, Bioproduction and Others), End User (Biopharma, CROs, (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) https://www.databridgemarketresearch.com/reports/middle-east-and-africa-transfection-reagents-and-equipment-market

Cancer Diagnostics Market, By Product (Consumables, Instruments), Type (Imaging Testing, Biomarkers Testing, In Vitro Diagnostic Testing, Biopsy, Others), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma Cancer, Prostate Cancer, Liver Cancer, Others), End-User (Diagnostic Centres, Hospitals and Clinics, Research Institutes, Others) https://www.databridgemarketresearch.com/reports/global-cancer-diagnostics-market

Arthritis Market, By Rheumatoid Drug Type (Biologics, Non-Biologics, Steroids, Analgesics, Glucocorticoids, Others), Rheumatoid Treatment (Synovectomy, Tendon Repair, Joint Fusion, Symptomatic Treatment, Intermediate Corticosteroid Therapies, DMARD Therapies), Rheumatoid Diagnosis (CRP Test, CCP, ESR Test), Osteoarthritis Type (Hip, Spinal, Knee, Foot and Ankle, Shoulder, Hand), Osteoarthritis Treatment (Medication, Drugs, Assistive Devices, Surgery, Therapy), Osteoarthritis Diagnosis (Imaging, Joint Fluid Analysis, Others), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Clinics, Household, Medical Institutes, Research Organizations, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Drug Stores), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-arthritis-market

Artificial Intelligence in Medical Imaging Market, By Technology (Deep Learning, Computer Vision, NLP, Others), Offering (Hardware, Software, Services), Deployment Type (On-Premise, Cloud), Application (X-Ray, CT, MRI, Ultrasound, Molecular Imaging), Clinical Applications (Breast, Lung, Neurology, Cardiovascular, Liver, Prostate, Colon, Musculoskeletal, Others), End-User (Hospitals, Clinics, Research Laboratories, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-artificial-intelligence-in-medical-imaging-market

Aspirin Market, By Route of Administration (Oral, Rectal, Parenteral), Dosage Form (Tablets, Capsules, Injections, Suppositories), Applications (Pain, Fever and Inflammation, Deep Vein Thrombosis and Others), Dose Type (Adult Dose and Pediatric Dose), Availability (Prescription and OTC), Product Type (Alone and Combination Products), End User (Hospitals, Clinics, Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-aspirin-market

Injectable Drug Delivery Market, By Type (Injectable Drug Delivery Devices, Injectable Drug Delivery Formulation), Formulation Packaging (Ampoules, Vials, Cartridges, Bottles), Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Cancer, Others),  Usage Pattern (Curative Care, Immunization, Other), Site Of Administration (Skin, Circulatory/Musculoskeletal System, Organs, Central Nervous System), Distribution Channel (Hospital, Retail Pharmacy Stores), End User (Hospitals and Clinics, Home Care Settings, Others) https://www.databridgemarketresearch.com/reports/global-injectable-drug-delivery-market

Topical Drug Delivery Market, By Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products), Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery), Distribution Channel (Direct Tenders, Retail), End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others) https://www.databridgemarketresearch.com/reports/global-topical-drug-delivery-market

North America Topical Drug Delivery Market, Product Type (Drug Delivery Formulations and Drug Delivery Devices), Delivery Techniques (Ionotophoresis, Sonophoresis, Laser Ablation, Radio Frequency Ablation, Magnetophoresis, Electroporation And Others), Type (Cleansing Agents, Protective Agents, Moisturizing Agents, Drying Agents, Anti-Itch Agents, Anti-Inflammatory Agents, Anti-Infective Agents, Keratolytics, and Others), Generation (First Generation Transdermal Delivery Systems, Second Generation Transdermal Delivery Systems and Third Generation Transdermal Delivery Systems), Mode of Purchase (Prescription and Over The Counter), Indication (Dermatological Disorders, Ophthalmic Disorders, Pain Management, Neurosurgical Disorders, Hormonal Therapy, Smoking Cessation and Others), Route of Administration (Dermal, Ophthalmic, Rectal, Vaginal, Nasal and Others), End User (Hospitals, Specialty Centers, Home Healthcare, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others) https://www.databridgemarketresearch.com/reports/north-america-topical-drug-delivery-market

Drug Delivery Devices Market, By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Others), Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Others) https://www.databridgemarketresearch.com/reports/global-drug-delivery-devices-market

North America Drug Delivery Devices Market, By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery and Implantable Drug Delivery), Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings and Others), Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders and Others), Country (U.S., Canada, Mexico) https://www.databridgemarketresearch.com/reports/north-america-drug-delivery-devices-market

Artificial Intelligence (AI) in Drug Discovery Market, By Application (Novel Drug Candidates, Drug Optimization and Repurposing Preclinical Testing and Approval, Drug Monitoring, Finding New Diseases Associated Targets and Pathways, Understanding Disease Mechanisms, Aggregating and Synthesizing Information, Formation & Qualification of Hypotheses, De Novo Drug Design, Finding Drug Targets of an Old Drug and Others), Technology (Machine Learning, Deep Learning, Natural Language Processing and Others), Drug Type (Small Molecule and Large Molecule), Offering (Software and Services), Indication (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases and Others), End Use (Contract Research Organizations (CROs), Pharmaceutical & Biotechnology Companies, Research Centers and Academic Institutes and Others) https://www.databridgemarketresearch.com/reports/global-artificial-intelligence-ai-in-drug-discovery-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

Logo: https://mma.prnewswire.com/media/1011053/Data_Bridge_Market_Research_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/transfection-reagent-and-equipment-market-estimated-to-witness-exponential-cagr-growth-of-9-6-by-2030--size-share-trends-rising-demand-dynamics-and-opportunity-analysis-301771454.html

SOURCE Data Bridge Market Research

FAQ

What does the new report on transfection reagent and equipment market cover?

The report analyzes growth strategies, opportunities, and the competitive landscape of the global transfection reagent and equipment market.

What is the expected market value for transfection reagents by 2030?

The global transfection reagent and equipment market is expected to reach USD 2,284,494.00 thousand by 2030.

What factors are driving growth in the transfection reagent market?

Key drivers include the rise in chronic diseases, demand for gene therapy, and exploration of emerging markets.

What are some of the challenges facing the transfection reagent market?

Challenges include high instrument costs, selective reagent effectiveness, and potential cell damage from transfection methods.

Who are the major players in the transfection reagent and equipment market?

Notable players include Mirus Bio, Promega Corporation, and Bio-Rad Laboratories.